We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$13.8B
AUM Growth
-$581M
(-4%)
Cap. Flow
-$2.79B
Cap. Flow
% of AUM
-20.16%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
905
New
29
Increased
148
Reduced
448
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$66.4M |
| 2 |
Valero Energy
VLO
|
+$28.9M |
| 3 |
SLB Ltd
SLB
|
+$24.8M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$22.6M |
| 5 |
PepsiCo
PEP
|
+$20.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$182M |
| 2 |
Apple
AAPL
|
+$148M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$90.9M |
| 4 |
Amgen
AMGN
|
+$72.1M |
| 5 |
Tesla
TSLA
|
+$66.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.26% |
| 2 | Technology | 28.78% |
| 3 | Financials | 8.15% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Primerica
PRI
$9.81B
| – | – |
-16,702
| Closed | -$2.65M |
|
802
RB Global
RBA
$20.8B
| – | – |
-7,119
| Closed | -$368K |
|
803
Roblox
RBLX
$34B
| – | – |
-48,498
| Closed | -$2.01M |
|
804
Radian Group
RDN
$5.14B
| – | – |
-126,159
| Closed | -$2.57M |
|
805
RadNet
RDNT
$4.84B
| – | – |
-19,563
| Closed | -$451K |
|
806
RELX
RELX
$60.1B
| – | – |
-79,921
| Closed | -$2.39M |
|
807
Repligen
RGEN
$7.44B
| – | – |
-5,668
| Closed | -$878K |
|
808
Reinsurance Group of America
RGA
$15.7B
| – | – |
-29,528
| Closed | -$3.61M |
|
809
Sunrun
RUN
$2.37B
| – | – |
-240,163
| Closed | -$4.45M |
|
810
SEI Investments
SEIC
$11.9B
| – | – |
-6,495
| Closed | -$344K |
|
|
SEM
811
DELISTED
Select Medical
SEM
| – | – |
-33,774
| Closed | -$433K |
|
|
SGMO
812
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| – | – |
-202,674
| Closed | -$328K |
|
813
Surgery Partners
SGRY
$2.06B
| – | – |
-15,145
| Closed | -$481K |
|
814
SiriusXM
SIRI
$10B
| – | – |
-16,759
| Closed | -$612K |
|
|
SKX
815
DELISTED
Skechers
SKX
| – | – |
-46,338
| Closed | -$2.03M |
|
816
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| – | – |
-22,500
| Closed | -$208K |
|
817
Sociedad Química y Minera de Chile
SQM
$19.6B
| – | – |
-231,676
| Closed | -$17.3M |
|
818
Stagwell
STGW
$1.84B
| – | – |
-71,317
| Closed | -$487K |
|
819
Theravance Biopharma
TBPH
$874M
| – | – |
-44,489
| Closed | -$444K |
|
820
Teladoc Health
TDOC
$1.58B
| – | – |
-39,019
| Closed | -$930K |
|
821
Bio-Techne
TECH
$11.2B
| – | – |
-15,192
| Closed | -$1.04M |
|
822
Teradyne
TER
$54.8B
| – | – |
-8,774
| Closed | -$868K |
|
|
TGNA
823
DELISTED
TEGNA Inc
TGNA
| – | – |
-103,413
| Closed | -$1.61M |
|
824
TriNet
TNET
$2.84B
| – | – |
-67,413
| Closed | -$5M |
|
|
TPIC
825
DELISTED
TPI Composites
TPIC
| – | – |
-395,804
| Closed | -$4.75M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2023 Portfolio in Review
As of Q2 2023, Candriam SCA held 905 positions worth $13.8B, down 4% from $14.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $2.79B in Q2 2023, closing 194 positions and reducing 448 holdings. Its most notable exit was Thomson Reuters, an estimated $19.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Vir Biotechnology worth $8.7M.
- Candriam SCA's largest Q2 2023 buy was Vir Biotechnology: 354,645 shares worth $8.7M.
- Candriam SCA added most to Lam Research in Q2 2023, an estimated $66.4M increase.
- Candriam SCA's biggest Q2 2023 reduction was Microsoft, cutting an estimated $182M.
- Candriam SCA fully exited Thomson Reuters in Q2 2023, selling an estimated $19.8M.
- Candriam SCA's ten largest holdings make up 25% of its $13.8B portfolio in Q2 2023.
- Candriam SCA opened 29 new positions and closed 194 in Q2 2023.
- Candriam SCA's portfolio value fell 4% quarter-over-quarter to $13.8B.
Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.